🇺🇸 FDA
Patent

US 11898158

Methods and compositions for the treatment of lysosomal storage diseases

granted A61KA61K35/407A61K38/465

Quick answer

US patent 11898158 (Methods and compositions for the treatment of lysosomal storage diseases) held by Sangamo Therapeutics, Inc. expires Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sangamo Therapeutics, Inc.
Grant date
Tue Feb 13 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K35/407, A61K38/465, A61K38/47, A61K48/00